CTRI/2021/07/035099尚未招募2 期
Evaluation of Parisheka Basti and Virechana with Navkarshik Kwath in Vatarakta with special reference to Scleroderma
PATANJALI AYURVED COLLEGE0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age 20-60 years; 2. Patients fulfil the criteria of Vatarakta (Scleroderma); 3. Patients with Limited Cutaneous Systemic Sclerosis (LCSS); 4. CREST (Calcinosis, Raynaudâ??s, Oesophageal involvement, Sclerodactyly and Telangiectasia) Syndrome; 5. Chronicity between 6 weeks to 10 years with not less than 30% involvement of body surface.; 6. Digital Ulcers; 7. Patients who are fit for Basti Karma and Virechana Karma
排除标准
- •1. Age less than 20 and more than 60 years; 2. Diffuse Cutaneous Systemic Sclerosis; 3. Patients with traumatic, malignant and chronic wound; 4. Pregnancy & lactating mothers; 5. Any other systemic disorders; 6. Patients who are unfit for Basti Karma and Virechana Karma
研究者
相似试验
已完成
3 期
Assess the Effect of Daily Purgation therapy with small doses of medicine alongwith External panchakarma therapy in Diabetic peripheral neuropathy diseaseCTRI/2022/03/041400Institute of Teaching and Research in Ayurveda20
尚未招募
2 期
â??EVALUATION OF RUKSHA VIRECHANA AND SNIGADHA VIRECHANA IN AMAVATA â??(RHEUMATOID ARTHRITIS)â??CTRI/2021/08/035355Patanjali Ayurvedic College Haridwar Patanjali Bhartiya Anusandhan Sansthan Haridwar
暂停
2 期
Role of Vamana (Medicated Emesis) and Virechana (Medicated Purgation) karma (Procedure) in the treatment of the Patients of HypothyroidismCTRI/2021/03/031901Dr Ashish Mehta
尚未招募
2 期
To see the effect of Netra Parisheka and Aschyotana along with Mahatriphaladi Ghrit in Vataj Abhishyanda.CTRI/2024/07/070970Patanjali Bhartiya Ayurvigyan evam Anusandhan Sansthan Haridwar
尚未招募
2 期
Treatment of Children cases of white patches (Safed dag) by application Ayurvedic drug and Ayurvedeeya procedures of body cleaning.CTRI/2018/05/013844Dr Shrinidhi Kumar k